Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics

2 years ago

RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studiesTollovid biomarker data to support potential structure-function claims in Long…

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

2 years ago

Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 5 August 2022 — This document…

Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering

2 years ago

ASHBURN, Va., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage,…

Addiction Medicine Doctor Tampa, Florida – Dr. Hardeep Singh Named to Tampa Magazines’ 2022 Top Doctors List

2 years ago

Tampa, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The team at Turning Point of Tampa is proud to congratulate Dr. Hardeep…

Castellum, Inc. Announces Record Quarterly Revenue

2 years ago

Castellum, Inc. Announces Record Quarterly Revenue Revenue for Q2 2022 was approximately $11 million - Castellum, Inc. (OTC: ONOV) -…

Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering

2 years ago

NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech…

Tarsus Initiates Phase 2a Ersa Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease

2 years ago

IRVINE, Calif., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet…

Humacyte to Present Second Quarter 2022 Financial Results and Provide Recent Corporate Update on August 12, 2022

2 years ago

DURHAM, N.C., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable…

electroCore to Participate at Canaccord Genuity 42nd Annual Growth Conference

2 years ago

ROCKAWAY, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that…

BriaCell Secures License for a Promising Novel Anti-Cancer Agent

2 years ago

PHILADELPHIA and VANCOUVER, British Columbia, Aug. 04, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”…